Skip to main content
BAX logo

Baxter International Inc

Exchange: NYSESector: HealthcareIndustry: Medical Instruments & Supplies

Every day, Baxter and the Baxter Foundation strive to make a meaningful difference in the lives of people who depend on our products, and in the communities where our employees live and work. The Foundation helps advance Baxter's Mission to Save and Sustain Lives by partnering with organizations around the world to increase access to healthcare for the underserved, develop the next generation of innovators who will lead the way in advancing healthcare and create a positive, long-lasting impact in communities globally. For more information, please visit Baxter's Corporate Responsibility page. Baxter is a registered trademark of Baxter International Inc. or its subsidiaries. i Carey, Ben, et al., 2022, PLOS One ii Kline et al., 2020, Academic Emergency Medicine SOURCE Pet Partners

Did you know?

Free cash flow has been growing at -21.8% annually.

Current Price

$16.68

-0.60%

GoodMoat Value

$50.11

200.4% undervalued
Profile
Valuation (TTM)
Market Cap$8.57B
P/E-8.96
EV$16.27B
P/B1.40
Shares Out514.06M
P/Sales0.76
Revenue$11.24B
EV/EBITDA24.82

Baxter International Inc (BAX) Valuation

GoodMoat Analysis

Based on data as of March 26, 2026

Based on the GoodMoat target price of $50.11, Baxter International appears deeply undervalued, offering a theoretical margin of safety of over 190%. However, this assessment is complicated by the company's current negative profitability metrics and high debt, which require careful scrutiny of the underlying assumptions for the target price.

Read full analysis
The current price of $17.12 is dramatically lower than the GoodMoat target of $50.11. According to the framework's Discounted Cash Flow (DCF) bands, this implies a margin of safety of approximately 193%, which far exceeds the 40% threshold for being considered 'Deeply Undervalued.' This is the most compelling aspect of the valuation case. However, traditional multiples are less clear-cut. The negative P/E ratio of -9.2, driven by a GAAP loss of -$1.87 per share, is not directly comparable to a positive sector average and signals current financial distress. The stock's quality, as inferred from the provided metrics like a negative ROE of -15.6% and a high Debt/Equity ratio of 1.58, appears low, which typically justifies a discounted valuation. For a value investor, the key question is whether the target price is based on a credible recovery in profitability and cash flow. The positive Free Cash Flow Yield of 3.7% is a supportive data point, but the negative profit and operating margins suggest significant challenges. The valuation is dichotomous: it appears extremely cheap on a target price basis but is priced for distress on a trailing earnings basis, indicating the market has low confidence in a near-term turnaround. Analysis based on data as of 2024-07-19.

BAX Fair Value Estimate

$50.11200.4% undervalued

Blended fair value estimate based on DCF, Graham Number, and earnings-based models.

BAX Valuation Metrics

FCF$323.00M
FCF Growth Rate-21.76%
EPS Growth (CAGR)-21.76%
WACC10.00%

BAX Valuation & Fair Value Analysis

Baxter International Inc (BAX) valuation analysis using multiple fair value methodologies. GoodMoat calculates a blended fair value target using discounted cash flow (DCF) analysis, the Graham Number, and earnings-based valuation models.

The GoodMoat Fair Value target for Baxter International Inc is $50.11. The current stock price is $16.68, suggesting the stock is 200.4% undervalued.

The price-to-earnings (P/E) ratio is -8.96. Price-to-book ratio is 1.40. Price-to-sales ratio is 0.76. Enterprise value to EBITDA is 24.82. PEG ratio is -0.07.

GoodMoat's valuation models include the Graham Number (based on EPS and book value), an earnings-based model (discounted future EPS), and a PEG-adjusted valuation. The three models are averaged to produce a blended fair value estimate. Use these tools alongside the DCF calculator and reverse DCF to form a comprehensive view of Baxter International Inc's intrinsic value.